Posttranslational Modifications as Versatile Regulators of Parkin Function

E-ISSN： 1875-533x|18|16|2477-2485

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.16, 2011-06, pp. : 2477-2485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic #946; Cell Function: Potential Therapeutic Implications

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 2, 2002-07 ,pp. : 129-139

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Foxo-Dependent Transcription by Post-Translational Modifications

Current Drug Targets, Vol. 12, Iss. 9, 2011-08 ,pp. : 1303-1310

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 536-547

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Post-translational Modifications in Huntington’s and Parkinson’s Diseases

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5085-5092

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Post-translational Modifications to Target Memory-related Diseases

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5065-5075

Bentham Science Publishers

Access to resources Recommend Favorite